Health Care & Life Sciences » Pharmaceuticals | Sunflower Pharmaceuticals Group Co. Ltd.

Sunflower Pharmaceuticals Group Co. Ltd.

Sunflower Pharmaceuticals Group Co. Ltd.
Stock Exchange Shenzhen Stock Exchange
EPS
CNY0.99
Market Cap
CNY9.12 B
Shares Outstanding
516.78 M
Public Float
228.71 M

Profile

Address
No. 18 Donghu Road, Jizhong Area
Harbin Heilongjiang 150078
China
Employees -
Website http://www.kuihuayaoye.com
Updated 07/08/2019
Sunflower Pharmaceutical Group Co., Ltd. engages in the research and development, manufacturing, and marketing of pharmaceutical products. It focuses on proprietary Chinese medicines, chemical drugs, bio-pharmaceuticals, and tonic health care products. Its products include children's medication, digestive system medication, respiratory and cold medicine, gynecological drugs, rheumatism bone disease medication, and cardiovascular and cerebrovascular drugs.

Financials

View All
Created with Highcharts 5.0.14Sunflower Pharmaceuticals Group Co. Ltd.Net Income. Fiscal year is January-December. All values CNY Millions.2632633013013073073033034244245635632013201420152016201720180100200300400500600
Created with Highcharts 5.0.14Sunflower Pharmaceuticals Group Co. Ltd.Sales/Revenue. Fiscal year is January-December. All values CNY Millions.2 1522 1522 6622 6622 9832 9833 2893 2893 7873 7874 3974 39720132014201520162017201801k2k3k4k5k

Bao Dong Liu
Chairman-Supervisory Board
Yan Bin Guan
Chairman & General Manager